TurnCare, Inc. Announces John F. Milligan, PhD, former CEO of Gilead Sciences, joins Board of Directors
PALO ALTO, Calif., Jan. 11, 2024 /PRNewswire/ — TurnCare, a leading medical technology and services company dedicated to advancing how hospitals manage high acuity patients, is proud to announce the addition of John F. Milligan, Ph.D., investor, innovator, and former CEO of Gilead, to its Board of Directors.
Related news for (FDMT)
- Closing Bell Heat Check: Biotech Breakouts, Reverse Mergers & Moonshot Setups Heading into After-Hours
- Trade These, Not Those: Capital is Rotating and Here’s Where It’s Headed
- MoBot alert highlights: NASDAQ: CONI, NASDAQ: NAMM, NASDAQ: FDMT, NASDAQ: RAYA, NASDAQ: ADAP (08/01/25 04:00 AM)
- MoBot alert highlights: NASDAQ: MWYN, NASDAQ: NAMM, NASDAQ: IMG, NASDAQ: FDMT, NASDAQ: CETX (07/31/25 07:00 PM)
- MoBot alert highlights: NASDAQ: MWYN, NASDAQ: NAMM, NASDAQ: IMG, NASDAQ: FDMT, NASDAQ: CETX (07/31/25 06:00 PM)
